Cue Biopharma Inc.
CUE | NASDAQ
$27.60
-$0.67 (-2.37%)
Sep 22, 2026, 11:00 AM ET · Market open
Market Data
Market Cap $74.29M
Enterprise Value $59.98M
Beta 2.46
Average Volume 179.87K
Shares Outstanding (Diluted) 6.34M
Shares Change YoY 99.27%
Institutional Ownership 14.83%
Exchange NASDAQ
ISIN US22978P2056
Price Performance
Price Change 1M 22.4%
Price Change 3M 5.1%
Price Change 6M 256.5%
Price Change YTD 179.3%
Price Change 1Y 33.9%
Price Change 3Y -58.9%
Price Change 5Y -93.5%
1M CAGR (ann.) 4.2%
1Y CAGR (ann.) 29.1%
5Y CAGR (ann.) -40.3%
All-Time CAGR -25.0%
Valuation
PE Ratio -1.05
Forward PE N/A
PEG Ratio 0.00
Forward PEG 0.01
PS Ratio 1.97
Forward PS 8.60
PB Ratio 32.16
P/FCF Ratio -1.48
P/Adj. FCF Ratio -0.98
P/OCF Ratio -3.58
EV/Sales 1.59
EV/EBIT -0.61
EV/EBITDA -0.63
EV/FCF -1.20
Earnings Yield -95.5%
FCF Yield -67.5%
Adj. FCF Yield -102.6%
Financial Health
Net Cash $14.32M
Total Debt $3.08M
Cash & Short-Term Investments $17.39M
Total Assets $30.71M
Current Ratio 1.25
Quick Ratio 1.25
Debt / Equity Ratio 3.81
Debt / EBITDA -0.03
Debt / FCF -0.06
OCF / Debt -16.26
Interest Coverage -730.70
Altman Z-Score -31.55
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 99.7%
Operating Profit Margin -262.0%
EBITDA Margin -254.7%
Net Profit Margin -435.8%
FCF Margin -133.2%
Adj. FCF Margin -202.4%
SBC / Revenue 69.1%
SBC Impact (per share) -51.9%
Returns
Return on Assets -534.4%
Return on Equity -1032.2%
Return on Invested Capital -887.3%
Return on Capital Employed -1039.6%
Return on Tangible Assets -534.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 176.2%
Revenue CAGR 5Y 47.1%
Revenue CAGR 10Y 32.4%
EPS CAGR 3Y 4.3%
EPS CAGR 5Y 18.4%
EPS CAGR 10Y 5.2%
FCF CAGR 3Y -14.8%
FCF CAGR 5Y -1.6%
FCF CAGR 10Y -28.5%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y 23.5%
Revenue Growth Next 3Y -36.4%
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$2.24
EPS Growth Est (next Q) 6.8%
Revenue Est (next Q) $1.03M
Revenue Growth Est (next Q) -51.9%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $4.33
Price Target Upside -84.7%
Cash Flow
Operating Cash Flow $-50.05M
Free Cash Flow $-50.17M
Adj. Free Cash Flow $-76.2M
FCF Per Share -$7.91
OCF Per Share -$7.89
OCF/S Ratio -132.9%
Income Statement
Revenue $37.65M
Gross Profit $37.54M
Operating Income $-98.64M
EBITDA $-95.89M
Net Income $-164.11M
EPS (Diluted) -$27
Revenue / Employee $1.3M
Profit / Employee $-5.66M
Employees 29
Add to Watchlist
Select watchlists to add or remove CUE